| Kenisha Mckinney, LISW | |
|
4100 W 3rd St Bldg 320, Dayton, OH 45428-9000 | |
| (937) 268-6511 | |
| Not Available |
| Full Name | Kenisha Mckinney |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 4100 W 3rd St Bldg 320, Dayton, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053050906 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kenisha Mckinney, LISW 4100 W 3rd St Bldg 320, Dayton, OH 45428-9000 Ph: () - | Kenisha Mckinney, LISW 4100 W 3rd St Bldg 320, Dayton, OH 45428-9000 Ph: (937) 268-6511 |
News Archive
A new study published on the preprint server medRxiv in June 2020 shows that immune cells, antibody levels, cytokine levels, and viral loads contribute to the sex difference seen in response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Researchers at the University of Michigan Comprehensive Cancer Center have identified a new imaging technique that can measure the effectiveness of treatment for prostate cancer that has spread to the bones.
Although having a high body mass index (BMI) is a known risk factor for cardiovascular disease, researchers are only beginning to understand how BMI affects the physiological processes involved in the development of the disease. Now, a study of a subset of women in the Kronos Early Estrogen Prevention Study (KEEPS), suggests that as BMI increases, so do platelet reactivity and thrombogenic microvesicles and activated protein C in the blood-all of which contribute to the formation of atherothrombosis and associated cardiovascular events.
Angiochem, Inc., a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB) through LRP-1 targeting, announced today that complete phase 1/2 clinical data in two clinical studies of its lead oncology program, ANG1005, for the treatment of brain cancers, including glioblastoma (GBM) and brain metastases, were presented at the 2010 American Society for Clinical Oncology (ASCO) Annual Meeting, June 4-8, in Chicago, IL.
› Verified 5 days ago
Carrie Cook Latt, LISW-S Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1010 Valley St, Dayton, OH 45404 Phone: 937-641-3401 Fax: 937-641-3046 | |
Elizabeth Dawn Morgan, MSW, LISW-S Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 289 Hilltop Dr, Dayton, OH 45415 Phone: 513-407-2944 | |
Ms. Mawausi Ssabah Arraheem, MSW, CSW, LICDC,LPN Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4100 W 3rd St, Dayton, OH 45428 Phone: 937-268-6511 | |
Holly T Lefevre, MSSA, LSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1 Childrens Plz, Dayton, OH 45404 Phone: 937-641-5300 Fax: 937-641-5134 | |
Nicholle Megan Bair, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4100 W 3rd St, Building 410, Dayton, OH 45428 Phone: 937-268-6511 | |
Stephanie Ann Bricker, LISW-S Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4100 W 3rd St, Dayton, OH 45428 Phone: 937-268-6511 | |
Danielle Marie Washington, MSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 455 Turner Rd, Dayton, OH 45415 Phone: 937-278-7861 |